IFNA5 抗体 (AA 24-189)
Quick Overview for IFNA5 抗体 (AA 24-189) (ABIN7140818)
抗原
See all IFNA5 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 24-189
- 
                                            交叉反应
- Cow
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Bovine Interferon alpha-G protein (24-189AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:1000-1:5000,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - IFNA5 (Interferon, alpha 5 (IFNA5))
- 
                                            别名
- IFNAG
- 
                                            背景
- 
                        Background: Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. Aliases: IFNAG antibody, IFNA7 antibody, Interferon alpha-G antibody, IFN-alpha7 antibody 
- 
                                            UniProt
- P49877
- 
                                            途径
- JAK/STAT Signaling, Hepatitis C
 抗原
- 
                    
 
                                     
                                     
                                    